Search Results
Search for other papers by Cecilia Lundin in
Google Scholar
PubMed
Search for other papers by Agota Malmborg in
Google Scholar
PubMed
Search for other papers by Julia Slezak in
Google Scholar
PubMed
Search for other papers by Kristina Gemzell Danielsson in
Google Scholar
PubMed
Search for other papers by Marie Bixo in
Google Scholar
PubMed
Search for other papers by Hanna Bengtsdotter in
Google Scholar
PubMed
Search for other papers by Lena Marions in
Google Scholar
PubMed
Search for other papers by Ingela Lindh in
Google Scholar
PubMed
Search for other papers by Elvar Theodorsson in
Google Scholar
PubMed
Search for other papers by Mats Hammar in
Google Scholar
PubMed
Search for other papers by Inger Sundström-Poromaa in
Google Scholar
PubMed
Introduction The effect of combined oral contraceptives (COCs) on female sexuality has long been a matter of discussion ( 1 ). According to a systematic review in the field, however, mainly based on observational studies, approximately 15% of
Search for other papers by Lina S Silva-Bermudez in
Google Scholar
PubMed
Search for other papers by Freddy J K Toloza in
Google Scholar
PubMed
Search for other papers by Maria C Perez-Matos in
Google Scholar
PubMed
Search for other papers by Russell J de Souza in
Google Scholar
PubMed
Search for other papers by Laura Banfield in
Google Scholar
PubMed
Search for other papers by Andrea Vargas-Villanueva in
Google Scholar
PubMed
Search for other papers by Carlos O Mendivil in
Google Scholar
PubMed
. Contraception 2004 69 271 – 278 . ( https://doi.org/10.1016/j.contraception.2003.11.003 ) 47 Klipping C Marr J Effects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospirenone or desogestrel on
Search for other papers by Vittorio Unfer in
Google Scholar
PubMed
Search for other papers by Fabio Facchinetti in
Google Scholar
PubMed
Search for other papers by Beatrice Orrù in
Google Scholar
PubMed
Search for other papers by Barbara Giordani in
Google Scholar
PubMed
Search for other papers by John Nestler in
Google Scholar
PubMed
BMI, body mass index; COC, combined oral contraceptive; DBRCT, double-blind randomized controlled trials; DCI, d -chiro-inositol; FA, folic acid; MI, myo-inositol; N, No; OCPs, oral contraceptive pills; RCT, randomized controlled trials; Y, Yes
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Malin Nylander in
Google Scholar
PubMed
Department of Internal Medicine, Endocrine Unit, Herlev Gentofte Hospital, Herlev, Denmark
Search for other papers by Signe Frøssing in
Google Scholar
PubMed
Department of Internal Medicine, Endocrine Unit, Herlev Gentofte Hospital, Herlev, Denmark
Search for other papers by Caroline Kistorp in
Google Scholar
PubMed
Department of Internal Medicine, Endocrine Unit, Herlev Gentofte Hospital, Herlev, Denmark
Search for other papers by Jens Faber in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Sven O Skouby in
Google Scholar
PubMed
, indicates hypercoagulability, as seen in users of combined oral contraceptives ( 12 ). Moreover, high thrombin generation is associated with first and recurrent VTE and possibly with coronary atherosclerosis ( 13 , 14 , 15 ). Thrombin generation has been
Search for other papers by Dorte Glintborg in
Google Scholar
PubMed
Search for other papers by Hanne Mumm in
Google Scholar
PubMed
Search for other papers by Jens Juul Holst in
Google Scholar
PubMed
Search for other papers by Marianne Andersen in
Google Scholar
PubMed
. European Journal of Endocrinology 1998 3 269 – 274 . ( doi:10.1530/eje.0.1380269 ) 14 Costello M Shrestha B Eden J Sjoblom P Johnson N. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne
Department of Endocrinology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
Search for other papers by Sophie Howarth in
Google Scholar
PubMed
Search for other papers by Luca Giovanelli in
Google Scholar
PubMed
Search for other papers by Catherine Napier in
Google Scholar
PubMed
Department of Endocrinology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
Search for other papers by Simon H Pearce in
Google Scholar
PubMed
history included levothyroxine 200 µg once daily, 3-monthly vitamin B12 injections, an actrapid/glargine basal bolus insulin regimen and the combined oral contraceptive pill (COCP). Eight years previously, she had been hospitalised for an episode of
Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden.
Search for other papers by Angelica Lindén Hirschberg in
Google Scholar
PubMed
OM . Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis . BMJ 2013 347 f5298 . ( https://doi.org/10.1136/bmj.f5298 )
Department of Science and Environment, Roskilde University, Roskilde, Denmark
Search for other papers by Pernille Bækgaard Udesen in
Google Scholar
PubMed
Search for other papers by Dorte Glintborg in
Google Scholar
PubMed
Search for other papers by Anja Elaine Sørensen in
Google Scholar
PubMed
Search for other papers by Rikke Svendsen in
Google Scholar
PubMed
Department of Clinical Immunology, Næstved Hospital, Næstved, Denmark
Search for other papers by Nanna Louise Skov Nielsen in
Google Scholar
PubMed
Search for other papers by Marie Louise Muff Wissing in
Google Scholar
PubMed
Search for other papers by Marianne Skovsager Andersen in
Google Scholar
PubMed
Search for other papers by Anne Lis Mikkelsen Englund in
Google Scholar
PubMed
Search for other papers by Louise Torp Dalgaard in
Google Scholar
PubMed
.10.1257 ) 1397698 6 Teede H Tassone EC Piltonen T Malhotra J Mol BW Peña A Witchel SF Joham A McAllister V Romualdi D et al . Effect of the combined oral contraceptive pill and/or metformin in the management of PCOS: a systematic review with
Department of Endocrinology, Diabetes and Nutrition, University Hospital of Bordeaux, Bordeaux, France
Search for other papers by Virginie Grouthier in
Google Scholar
PubMed
Search for other papers by Zeina Chakhtoura in
Google Scholar
PubMed
Search for other papers by Isabelle Tejedor in
Google Scholar
PubMed
Search for other papers by Yasmina Badachi in
Google Scholar
PubMed
Search for other papers by Vincent Goffin in
Google Scholar
PubMed
Sorbonne Université, F-75013, Paris, France
Search for other papers by Philippe Touraine in
Google Scholar
PubMed
, decrease of −0.2 ± 0.03 mm per month of use, P < 0.0001). Regarding oral contraceptives, there was no association on the evolution of MFA, regardless of whether combined oral contraceptives (COC) or only progestin (75µg of desogestrel) were used
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland
Search for other papers by Agata Hanna Bryk-Wiązania in
Google Scholar
PubMed
Search for other papers by Mari Minasyan in
Google Scholar
PubMed
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland
Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland
Search for other papers by Aleksandra Gilis-Januszewska in
Google Scholar
PubMed
). These regimens were not applicable in our cohort, since most of the VTEs were not related to surgery but to other factors. Previous publications from our group have described these factors, which include puerperium ( 23 ), combined oral contraceptives